History of the reign of Ferdinand and Isabella, the Catholic /

Mode of access: Internet.

History of the reign of Ferdinand and Isabella, the Catholic.

Mode of access: Internet.

History of the reign of Ferdinand and Isabella, the Catholic /

Mode of access: Internet.

History of the reign of Ferdinand and Isabella the Catholic /

Mode of access: Internet.

History of the reign of Ferdinand and Isabella, the Catholic /

"Entered according to Act of Congress, in the year 1837 ..."--Verso of t.p.

History of the reign of Ferdinand and Isabella the Catholic /

Title on spine: History of Ferdinand and Isabella.

The History of the life and reign of the valiant Prince Edward, afterwards King Edward the first of England, son to King Henry the third; and his Princess Eleonora. On which history is founded a play written by Mr. Thomson, call'd Edward and Eleonora; now in rehearsal at the Theatre in Covent-Garden. Extracted from the best historians. With a geographical description of that Prince's expedition to the Holy Land.

Mode of access: Internet.

History of the reign of Ferdinand and Isabella, the Catholic /

Mode of access: Internet.

The Bruce; or, The book of the most excellent and noble prince, Robert de Broyss, king of Scots:

Paged continuously.

Za wolność i lud : opowiadania z lat 1861-1864 /

At end of text: Illustracye wypadków i wizerunki z lat 1861-1864, według rysunków A. Grottgera, W. Kossaka; współczesnych rycin, fotografii, i medali.

The period of mourning. Disposed into sixe visions. In memorie of the late prince. Together with nuptiall hymnes, in honour of this happy marriage betweene .. Frederick, Count Palatine of the Rhene, and ... Elizabeth onely daughter to our soueraigne, his maiestie. Also thr manner of the solemnization of the marriage at White-Hall ...

Mode of access: Internet.

History of the reign of Ferdinand and Isabella the Catholic /

Includes bibliographical references and index.

Predictive Value Of Phase I Trials For Safety In Later Trials And Final Approved Dose: Analysis Of 61 Approved Cancer Drugs.

Phase I trials use a small number of patients to define a maximum tolerated dose (MTD) and the safety of new agents. We compared data from phase I and registration trials to determine whether early trials predicted later safety and final dose. We searched the U.S. Food and Drug Administration (FDA) website for drugs approved in nonpediatric cancers (January 1990-October 2012). The recommended phase II dose (R2PD) and toxicities from phase I were compared with doses and safety in later trials. In 62 of 85 (73%) matched trials, the dose from the later trial was within 20% of the RP2D. In a multivariable analysis, phase I trials of targeted agents were less predictive of the final approved dose (OR, 0.2 for adopting ± 20% of the RP2D for targeted vs. other classes; P = 0.025). Of the 530 clinically relevant toxicities in later trials, 70% (n = 374) were described in phase I. A significant relationship (P = 0.0032) between increasing the number of patients in phase I (up to 60) and the ability to describe future clinically relevant toxicities was observed. Among 28,505 patients in later trials, the death rate that was related to drug was 1.41%. In conclusion, dosing based on phase I trials was associated with a low toxicity-related death rate in later trials. The ability to predict relevant toxicities correlates with the number of patients on the initial phase I trial. The final dose approved was within 20% of the RP2D in 73% of assessed trials.

Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance

In familial hyperaldosteronism type I (FH-I), inheritance of a hybrid 11 beta-hydroxylase/aldosterone synthase gene causes ACTH-regulated aldosterone overproduction. In an attempt to understand the marked variability in hypertension severity in FH-I, we compared clinical and biochemical characteristics of 9 affected individuals with mild hypertension (normotensive or onset of hypertension after 15 yr, blood pressure never >160/100 mm Hg, less than or equal to 1 medication required to control hypertension, no history of stroke, age >18 yr when studied) with those of 17 subjects with severe hypertension (onset before 15 yr, or systolic blood pressure >180 mm Hg or diastolic blood pressure >120 mm Hg at least once, or greater than or equal to 2 medications, or history of stroke). Severe hypertension was more frequent in males (11 of 13 males vs. 6 of 13 females; P

Collagen Type I may Influence the Expression of E-Cadherin and Beta-catenin in Carcinoma Ex-pleomorphic Adenoma

Carcinoma ex-pleomorphic adenoma (CXPA) is an aggressive salivary gland malignancy, usually derived from a long-standing or a recurrent benign tumor, the pleomorphic adenoma (PA). In the context of dynamic reciprocity, changes in the composition and structure of extracellular matrix proteins and cell surface receptors have been frequently associated with dysfunctional adhesion and invasive behavior of tumor cells. It is not fully understood if these changes are involved in the conversion of PA to CXPA. In this study, different progression stages of CXPA were investigated regarding the expression of the major extracellular matrix proteins, collagen type I, and of E-cadherin and beta-catenin, the components of adherens junctions. By immunohistochemical analysis, we have demonstrated that direct contact of tumor cells with fibrillar type I collagen, particularly near the invasive front and in invasive areas prevailing small nests of CXPA cells, could be associated with reduced expression of the E-cadherin and beta-catenin adhesion molecules and with invasive behavior of epithelial; but not of CXPA with myoepithelial component. Our results also suggested that this association could depend on the organization of collagen molecules, being prevented by high-order polymeric structures. These findings could implicate the local microenvironment in the transition from the premalignant PA to invasive CXPA.